单剂量psilocybin促进神经元在轨道前皮层的细胞类型特定的变化
Ziran Huang1, Xiaoyan Wei1, Yihui Wang1
1Department of Neurobiology, School of Basic Medical Sciences and National Institute on Drug Dependence, Peking University, Beijing, 100191, China.
概括
一种迷幻药类的psilocybin通过影响特定的神经元来改变大脑功能. 这项研究揭示了psilocybin如何影响轨道前皮层的第5层金字塔神经元,为其治疗心理障碍的治疗潜力提供了见解.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 分子生物学分子生物学
背景情况:
- 西在治疗抑郁症等心理障碍方面表现有前途.
- 精确的大脑机制和西的细胞特异性作用尚未完全理解.
- 轨道前皮层 (OFC) 与抑郁症和其他心理障碍有关.
研究的目的:
- 为了研究长期,细胞类型特异性的西对OFC的影响.
- 为了阐明OFC神经元中psilocybin诱导的分子和功能变化.
- 确定5-HT2A受体在西宾的作用中的作用.
主要方法:
- 单核RNA测序 (snRNA-seq) 用于分析基因表达变化.
- 功能性测试用于评估神经元活动和突触传播.
- 基因操纵 (敲击) 来研究受体功能.
主要成果:
- 单剂量psilocybin诱导了OFC神经元的长期遗传和功能变化,特别是第5层金字塔神经元.
- 西降低了这些神经元中的谷氨酸受体表达,并降低了这些神经元中的刺激性突触传输.
- 抑制性神经元 (帕尔瓦尔胺和索马托斯塔丁阳性) 的变化很小.
- 针对5层金字塔神经元中的5-HT2A受体,但不是抑制神经元,扭转了psilocybin的作用.
结论:
- 在OFC中,psilocybin对细胞类型具有特定的影响,主要影响第5层金字塔神经元.
- 这些发现突出了激发性神经元调节在西治疗作用中的作用.
- 这项研究有助于理解迷幻效应的神经基础以及潜在的大脑区域特定差异.
相关概念视频
01:25Dose-Response Relationship: Selectivity and Specificity
9.7K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.7K
01:58Cell Specific Gene Expression
16.5K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.5K
02:40The Eukaryotic Promoter Region
18.8K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
01:19Nervous Tissue: Neuron Types
6.3K
Neurons, the fundamental units of the nervous system, can be classified based on both their structural and functional characteristics.
Structurally, neurons are categorized into three main types: multipolar, bipolar, and unipolar (or pseudounipolar). Multipolar neurons, which are the most common type in the brain and spinal cord, as well as all motor neurons, possess multiple dendrites and a single axon.
Bipolar neurons, on the other hand, have one primary dendrite and one axon. They are...
Structurally, neurons are categorized into three main types: multipolar, bipolar, and unipolar (or pseudounipolar). Multipolar neurons, which are the most common type in the brain and spinal cord, as well as all motor neurons, possess multiple dendrites and a single axon.
Bipolar neurons, on the other hand, have one primary dendrite and one axon. They are...
6.3K
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
240
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
240
01:21Dose Size and Dosing Frequency: Determination Methods
302
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
302